Singapore-based medical technology company Accuron Technologies has acquired the majority of stakes in Malaysia-based Aurum Healthcare.
The recent acquisition marks the sixth such investment carried out by Accuron Medtech in the field of healthcare.
Accuron Medtech group CEO Abel Ang said: “Accuron Medtech welcomes Aurum Healthcare into our family of medtech businesses, which include Advanced Materials Technologies, Dornier MedTech and Veredus Laboratories.
“Our operating businesses provide therapeutic, diagnostic and medical device solutions to customers internationally through our direct presence in the US, Europe, China, Japan and Singapore.
“By adding a commercial and manufacturing presence in Malaysia through Aurum, we believe this deal will be beneficial for our group operating companies.
“Accuron Medtech companies can leverage upon each other’s capabilities, networks and expertise in order to maximise their market and technology reach.”
Following the acquisition, Aurum will be placed under the banner of Advanced Materials Technologies (AMT), which is a contract manufacturer focused on the medtech sector, based in Singapore.
It is expected to augment AMT’s manufacturing capacity in its 120,000ft² facilities located in Tuas, Singapore and Dongguan City, China including Aurum’s 20,000ft² facility at the Setia Business Park, in Johor Bahru, Malaysia.
Aurum’s facility will offer sterilisation services for medical devices and instruments along with clean room manufacturing and assembly services.
AMT offers metal injection molding and 3D metal printing for high-precision and complex metal parts used in the medical device sector.
The company caters to the urology, endoscopy and robotic surgery fields.
Aurum’s capabilities are expected to bolster AMT’s original equipment manufacturer (OEM) to include manufacturing of plastic medical consumables.
